Literature DB >> 12854126

Diverticular disease of the colon: new perspectives in symptom development and treatment.

Antonio Colecchia1, Lorenza Sandri, Simona Capodicasa, Amanda Vestito, Giuseppe Mazzella, Tommaso Staniscia, Enrico Roda, Davide Festi.   

Abstract

Diverticular disease of the colon is a common disease worldwide. Although the disease is asymptomatic in about 70-80 % of patients, it represents, at least in Western countries, one of the most important gastrointestinal diseases in terms of direct and indirect health costs. Pathogenesis of the disease is still unknown. However, it is the result of complex interactions between colonic structure, intestinal motility, diet and genetic factors. Whilst efficacious preventive strategies remain to be identified, fibre supplementation in the diet is recommended. Why symptoms develop is still unclear. Results of recent experimental studies on irritable bowel syndrome speculated that low grade inflammation of colonic mucosa, induced by changes in bacterial microflora, could affect the enteric nervous system, which is crucial for normal gut function, thus favouring symptom development. This hypothesis could be extrapolated also for diverticular disease, since bacterial overgrowth is present, at least in a subgroup of patients. These perspectives on symptom development are reviewed and new therapeutic approaches are hypothesized.

Entities:  

Mesh:

Year:  2003        PMID: 12854126      PMCID: PMC4615468          DOI: 10.3748/wjg.v9.i7.1385

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  67 in total

1.  Diagnosis and management of diverticular disease of the colon in adults. Ad Hoc Practice Parameters Committee of the American College of Gastroenterology.

Authors:  N H Stollman; J B Raskin
Journal:  Am J Gastroenterol       Date:  1999-11       Impact factor: 10.864

2.  Axonal damage in Crohn's disease is frequent, but non-specific.

Authors:  D B Brewer; H Thompson; I G Haynes; J Alexander-Williams
Journal:  J Pathol       Date:  1990-08       Impact factor: 7.996

3.  Substance P containing nerve fibers in rectal mucosa of ulcerative colitis.

Authors:  T Watanabe; Y Kubota; T Muto
Journal:  Dis Colon Rectum       Date:  1997-06       Impact factor: 4.585

4.  Diet and diverticulitis.

Authors:  W W Davey
Journal:  Br Med J       Date:  1968-01-13

Review 5.  Putative inflammatory and immunological mechanisms in functional bowel disorders.

Authors:  S M Collins; B Vallance; G Barbara; M Borgaonkar
Journal:  Baillieres Best Pract Res Clin Gastroenterol       Date:  1999-10

6.  High fibre diet in symptomatic diverticular disease of the colon.

Authors:  A L Leahy; R M Ellis; D S Quill; A L Peel
Journal:  Ann R Coll Surg Engl       Date:  1985-05       Impact factor: 1.891

Review 7.  A role for inflammation in irritable bowel syndrome?

Authors:  G Barbara; R De Giorgio; V Stanghellini; C Cremon; R Corinaldesi
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

8.  Acute left colonic diverticulitis in young patients.

Authors:  P Ambrosetti; J H Robert; J A Witzig; D Mirescu; P Mathey; F Borst; A Rohner
Journal:  J Am Coll Surg       Date:  1994-08       Impact factor: 6.113

9.  Cereal dietary fiber consumption and diverticular disease: a lifespan study in rats.

Authors:  N Fisher; C S Berry; T Fearn; J A Gregory; J Hardy
Journal:  Am J Clin Nutr       Date:  1985-11       Impact factor: 7.045

10.  Are fibre supplements really necessary in diverticular disease of the colon? A controlled clinical trial.

Authors:  M H Ornstein; E R Littlewood; I M Baird; J Fowler; W R North; A G Cox
Journal:  Br Med J (Clin Res Ed)       Date:  1981-04-25
View more
  17 in total

1.  Allergic predisposition, histamine and histamine receptor expression (H1R, H2R) are associated with complicated courses of sigmoid diverticulitis.

Authors:  Burkhard H A von Rahden; Christian Jurowich; Stefan Kircher; Maria Lazariotou; Matthias Jung; Christoph-Thomas Germer; Martin Grimm
Journal:  J Gastrointest Surg       Date:  2011-09-29       Impact factor: 3.452

2.  Efficacy of long term cyclic administration of the poorly absorbed antibiotic Rifaximin in symptomatic, uncomplicated colonic diverticular disease.

Authors:  Antonio Colecchia; Amanda Vestito; Francesca Pasqui; Giuseppe Mazzella; Enrico Roda; Francesca Pistoia; Giovanni Brandimarte; Davide Festi
Journal:  World J Gastroenterol       Date:  2007-01-14       Impact factor: 5.742

3.  Diverticular disease: paradigm shifts in pathogenesis and treatment.

Authors:  Keta K Vaidya; Martin H Floch
Journal:  Curr Treat Options Gastroenterol       Date:  2015-03

4.  Hand-assisted laparoscopic sigmoid resection for diverticular disease: 100 consecutive cases.

Authors:  T J Wilhelm; A Refeidi; P Palma; T Neufang; S Post
Journal:  Surg Endosc       Date:  2006-01-21       Impact factor: 4.584

Review 5.  Fiber and colorectal diseases: separating fact from fiction.

Authors:  Kok-Yang Tan; Francis Seow-Choen
Journal:  World J Gastroenterol       Date:  2007-08-21       Impact factor: 5.742

6.  Italian consensus conference for colonic diverticulosis and diverticular disease.

Authors:  Rosario Cuomo; Giovanni Barbara; Fabio Pace; Vito Annese; Gabrio Bassotti; Gian Andrea Binda; Tino Casetti; Antonio Colecchia; Davide Festi; Roberto Fiocca; Andrea Laghi; Giovanni Maconi; Riccardo Nascimbeni; Carmelo Scarpignato; Vincenzo Villanacci; Bruno Annibale
Journal:  United European Gastroenterol J       Date:  2014-10       Impact factor: 4.623

Review 7.  Therapeutical use of probiotic formulations in clinical practice.

Authors:  T Iannitti; B Palmieri
Journal:  Clin Nutr       Date:  2010-06-23       Impact factor: 7.324

8.  Practice parameters for the treatment of colonic diverticular disease: Italian Society of Colon and Rectal Surgery (SICCR) guidelines.

Authors:  G A Binda; R Cuomo; A Laghi; R Nascimbeni; A Serventi; D Bellini; P Gervaz; B Annibale
Journal:  Tech Coloproctol       Date:  2015-09-16       Impact factor: 3.781

9.  Management of colonic diverticular disease with poorly absorbed antibiotics and other therapies.

Authors:  Federico Sopeña; Angel Lanas
Journal:  Therap Adv Gastroenterol       Date:  2011-11       Impact factor: 4.409

10.  Rifaximin: recent advances in gastroenterology and hepatology.

Authors:  Gary R Lichtenstein
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.